Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD

Completed · Phase 2 · Has a placebo group

Conditions studied: Attention Deficit Disorder With Hyperactivity

In brief

Evaluate the behavioral effects of MTS in children aged 6-12 with ADHD

Key facts

Study ID

NCT00466791

Run by

Noven Therapeutics

People needed

93

Starts

2004-08-01

Expected to finish

2005-05-01

Last updated by the study team

2015-06-25

Who can join

Age: 6 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Primary diagnosis ADHD
• Total score of greater than or equal to 26 on ADHD-RS-IV
• IQ of greater than or equal to 80
• Blood pressure measurements within 95th percentile for age, gender, height at screening and baseline

You may not qualify if…

• Current controlled (requiring a restricted medication) or uncontrolled, comorbid psychiatric diagnosis (except ODD)
• Known nonresponder to psychostimulant treatment
• BMI for age greater than 90th percentile
• History of seizures during last 2 years
• Conduct Disorder

Where it is running

• UCI Child Development Center — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.